Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02306980 · ClinicalTrials.gov registry record · NA
Oral Administration of Colostrum to Premature Babies: Impact on the Oral Microbiota
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT02306980 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 12 participants.
The verdict
NCT02306980, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Oropharyngeal administration of mother's colostrum to premature infants has been proposed as a stimulus to the oropharyngeal lymphatic tissues to decrease the incidence of pneumonia and sepsis, particularly in intubated babies. We propose to study the impact of this intervention on the composition of the oral microbiota.
Interventions
- OTHER Colostrum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2013-10 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02306980
The ClinicalTrials.gov registry entry for NCT02306980 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Colostrum is the first listed.
NCT02306980 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02306980 about?
NCT02306980 is a clinical study titled "Oral Administration of Colostrum to Premature Babies: Impact on the Oral Microbiota". Oropharyngeal administration of mother's colostrum to premature infants has been proposed as a stimulus to the oropharyngeal lymphatic tissues to decrease the incidence of pneumonia and sepsis, particularly in intubated babies. We propose to study the impact of this intervention on the composition o...
What is the current status of trial NCT02306980?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2013-10. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02306980?
The interventions under investigation include: Colostrum (OTHER).
Who is sponsoring clinical trial NCT02306980?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.